Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good news out today! Great results on human studies. IMO it'll create a nice little bump up for a higher platform before the big launch (when distribution news breaks)!
Adamis Pharma Highlights Excerpts From Abstract Of Presentation 'Human Factors Study of A Newly Approved Epinephrin...' At AAAAI Congress
Today 9:11 AM ET (Benzinga)Print
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) today provided an update on data from its presentation entitled “Human Factors Study of A Newly Approved Epinephrine Prefilled Syringe (Symjepi) for the Emergency Treatment of Allergic Reactions (Type I) Including Anaphylaxis”. The presentation took place at the American Academy of Allergy, Asthma, and Immunology (AAAAI) joint congress with the World Allergy Organization in Orlando, Florida on March 3, 2018.
Excerpts from the presentation’s Abstract were as follows:
Introduction: Epinephrine remains the treatment of choice for acute anaphylaxis. However, currently available auto-injectors are costly, and studies have demonstrated human factor issues resulting in incorrect use (lacerations) as well as device failures. Correct auto-injector use has been noted to be as low as 20% in some studies. A recently FDA approved prefilled syringe of epinephrine for the treatment of anaphylaxis (Symjepi™) was examined in a prospective human factors validation study in order to determine the likelihood that the product would be used safely and effectively by intended users.
Methods: A total of 82 participants were enrolled in this prospective study including adults with and without epinephrine injector experience, adolescents with and without epinephrine injector experience, and lay caregivers with and without epinephrine injector experience. Half of the participants in each user group were trained to use Symjepi™ prior to first use in the study. Critical tasks that could cause harm and compromise the successful use of epinephrine were assessed and included five categories: Open the case (I), retrieve prefilled syringe (II), remove needle cap (III), insert needle in the thigh (IV), press plunger until it stops (V).
Results: 100 % (82/82) of participants were able to complete task I. 100% (82/82) of participants completed task II. 100% (82/82) were able to complete task III. 93% (77/82) completed task IV and 99% (81/82) completed task V.
Dr. Ronald Moss, Chief Medical Officer at Adamis and a Fellow of AAAAI stated, “Human factor studies are important to support the safe and effective use of epinephrine devices used in the treatment of anaphylaxis. This prospective human factor study for this epinephrine device supports the ease and correct use of Symjepi™ for the acute treatment of anaphylaxis. Symjepi™ is a newly approved epinephrine syringe for the treatment of anaphylaxis and should provide a good cost-effective user-friendly alternative to current auto-injectors.”
I'm with you! Fools gold to some, but solid DD and transparent CEO show there's much more than meets the PPS eye! Looking forward to the AMFE future!
Do you really not see the GOOD news in this PR? Wow. Construction anywhere takes longer than normally expected. This franchise plan - rolled out barely 6 months ago - is already picking up steam with ACTUAL locations. IMO this is a rock solid investment, an investor's paradise. But it's definitely not a flipper's market, so maybe that's the big difference in our views....
What is dumber? A master plan shared to give investors the GENERAL idea of how they plan to expand? (Massively expand, I may add). OR to complain that taking an opportunity and seizing it to capitalize on revenue and continue to increase interest, while still generally sticking to the master plan, is a stupid move?????
I for one keep seeing very positive, promising things, but they will take time to develop. In that sense, I agree with the limited PR strategy of only massively distributing strong news. I'm happy to hold. Still higher lows than a few months ago. And great points to jump in or ADD. So - I'll be adding more soon.
That's the kind of news we needed....
This seems like it's in trouble....
Did someone issue a $1 target?
Another distributor! http://www.premierbiomedical.com/premier-biomedical-pain-relief-products-now-sold-through-okeechobee-discount-drugs/
Slowly but surely, the products are getting out there! #BIEIworlddomination
GREAT PR with more on the way, longs keep having good reasons to love what we hold... meanwhile, are you an SnL disgruntled ex-employee...didn't make the cut to work at Midtown? failed investor?! nothing you post on here has evidence or merit. Audit release will speak for itself so let's wait and see what that says before you post any more nonsense yeah?
As stated countless times on this board already... the ceo CAN'T do anything (more) about the Audit completion - it is in the auditors' hands. IF that was complete, and the uplist was taking forever, then you'd have a point.
Is THIS why we have an Admin Warning?!? Sheesh. Ridiculous post. Q2 was solid; audit questions have been dealt with 10000% and WILL be done soon (even though it's out of anyone's control), which means uplist, then BOOM, then you'll come back with your 'other side' whistling dixie here. I think you should not question the CEO's health when .... pot maybe calling the kettle here.
I'm cautiously optimistic today because as good as I think the Q2 results are, we need the uplist for the major buyers to come in. Sure, it could go up with a bunch of individuals like us, and I want more shares, but some deep-pocket hands will remain tied until uplist. Good news is, it'll be VERY SOON!
Promising news out today but... dang, 2.3 million sells in 1 minute?? (12:55-12:56)
Let's see how glad you still are in a couple of months!
Dozens (hundreds?) of us here NOT worried! We're LONG, and we know what we own
Let me add to your misinformed view: There is no Midtown. There was no whopping record revenue. And there is no queen of England!!!
It doesn't affect our share price much but those sells at 15's and 16 just scream of madness to me! Do they really don't know what they have here?? I guess some people just need quick liquidity but, sad....
Great news!
I agree. Congrats to your Eagles - what a game! Preview of great "underdog" winners like AMFE this year!
Well done! I for one learned a lot about analysis in this one post (humor helped keep it moving along)!
Geometry is beautiful isn't it? Specially when you link it to numbers, and the numbers and the patterns here line up swell. Thanks for posting.
This indeed will be a historic investment and posts like yours will probably be in future text books! haha! imagine that.
BTW, Anyone know what it will take to uplist back to QB? And how long? We have audited financials, and Mr. Hartman said they continue to have everything in place to meet the standards, so I wonder what the requirements are that the pps has to meet, etc....?
Yes, and we're getting what us longs want: higher lows... flippers can take their 3x and go home, I'm fine with that! I'm holding for 30x. Easy. Just takes patience with the direction this company is NOW heading (all due respect to longs who've been here 2+ years and have not seen it go anywhere). I think things will be different now, but that's just my hunch based on what I read & hear.
Nice! We know what we own....
Like Felo said, I was thankful for the delayed audit cause I was able to pick up a nice addition at a great price! The PR says more than enough, and the DD shows that #AMFE - as people have said here thousands of times - is the best you'll find on the OTC. Period. I'm taking the delay as a blessing to my future! I have a feeling a few others will too.
Perspective: Open, Highs, Lows, Close, Volume since Jan 12:
(I'm pretty happy with bouncing in the 005's today, consolidating, cause I know where we've been and I'm pretty sure of where we're going!!!!)
11:33 0.0069 0.007 0.0035 ? 12,575,137
01/30/2018 0.0072 0.0098 0.0064 0.0068 66,084,490
01/29/2018 0.0043 0.0063 0.0041 0.0063 47,416,340
01/26/2018 0.0038 0.0043 0.0036 0.0042 14,431,340
01/25/2018 0.0037 0.004 0.0035 0.0037 7,999,510
01/24/2018 0.0043 0.0043 0.0034 0.0036 13,222,470
01/23/2018 0.0032 0.0042 0.0032 0.0041 12,587,570
01/22/2018 0.0037 0.0037 0.0033 0.0035 2,810,287
01/19/2018 0.0033 0.0037 0.0029 0.0032 11,394,750
01/18/2018 0.0033 0.0034 0.0027 0.0031 4,336,842
01/17/2018 0.0035 0.0036 0.0025 0.0033 22,994,880
01/16/2018 0.0037 0.0037 0.0033 0.0035 3,322,748
01/12/2018 0.0032 0.0037 0.0032 0.0036 3,793,876
I seriously doubt you'll have the chance to buy again then! 12s? IMO, not likely.
Probably profit-taking. Many bought this at .0028 so it's almost a 3x's flip. Longs know we have 10x's that potential here, so we'll sit and let er gro
I agree, a little too much interest in penny-land can be NOT good. Slow and steady with long investors looking to make ten times more than flippers... that's who I'm inviting in. Meantime, I'll grab more!
Nope, enough longs here to ride the FACTS: Record Q numbers, brick and mortar franchises, Gro3 contracts, and on and on and on ... don't lie. I'm actually hoping news holds till late tomorrow cause I'll free up more funds by the morning!!!!
No, this guy:
(Carl Eller, President of the Retired P.A.):
The Retired Players Association is dedicated to providing powerful national advocacy and collegial support for retired professional football players, their families and the community at large. The RPA’s specific area of focus is to raise awareness and funding in support of medical research in the areas of Alzheimer’s and ALS, particularly as it relates to repeated head trauma. The RPA provides financial assistance for members suffering from these illnesses. Additionally, the RPA lobbies nationally for more comprehensive medical benefits for retired athletes.
Oh you've never made a mistake, right....??
Fact - Two words: Carl Eller. How do you explain that??? N.F.L.!!!
Seems like the New to the Street segment last Sunday on Fox Business News may have triggered a LOT of attention, it's the only explanation for the sudden volume surge.
There's a lot of good info a few pages back on the hub (posts have started mounting quickly!) including the latest CEO letter with a review of 2017 and plans for 2018 (I'll post that link below).
We (Longs) have been following everything in that newsletter over the past few months, including the NFL PA connection, the roll out of the hemp-based products online (with several headaches along the way), the dilution, the executive comp info, etc., etc. It's all legit, you can trace much of that news over the past 6 months or so. But of course, do your own research to validate!
http://www.premierbiomedical.com/premier-biomedical-inc-ceo-letter-january-2018/
PS - there's one particular cat on here with a handle that relates to cooking oil who a couple of weeks ago came out of nowhere to bash this stock, just FYI
Fact - Hartman's history includes: "At TRW Automotive, Mr. Hartman was one of the auto industry pioneers of the concept of grouping related components into systems and modules and shipping just-in-time to the vehicle assembly plants. He founded and headed a separate business group within TRW Automotive with plants in the U.S., Mexico and Europe with combined annual sales of $1.3 Billion."
Yeah, some scammer.....
Steady as she goes.... nice pace here. Glad to take our time all the way up to the penthouse! :)
Another Monster VOLUME day! 6 mill in first 10 minutes
I agree, and I think when the last Q report comes out there'll be a lot of excitement.
Anyone still hanging around here? I just noticed the steady rise of this company and wondered if it's going under the radar. From the looks of this board, it is!
For any new eyes doing some DD, this link summarizes BIEI's development very well, and packs a ton of info that, imo, makes this stock a must own: http://www.premierbiomedical.com/premier-biomedical-inc-ceo-letter-january-2018/
Go for it Atom! Btw, I think with the products and the timing (Opioid crisis) we're going to eventually blow the roof off and .02 will be a baseline, not a ceiling. Anyone think so?